Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is Cystic Fibrosis-related Diabetes Reversible? New Data on CFTR Potentiation and Insulin Secretion.

Literature DB >> 30192635

Is Cystic Fibrosis-related Diabetes Reversible? New Data on CFTR Potentiation and Insulin Secretion.

Andrew W Norris¹.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2019 PMID： 30192635 PMCID： PMC6363979 DOI： 10.1164/rccm.201808-1501ED

Source DB: PubMed Journal: Am J Respir Crit Care Med ISSN： 1073-449X Impact factor: 21.405

× No keyword cloud information.

13 in total

1. Resolution of cystic fibrosis-related diabetes with ivacaftor therapy.

Authors: Don Hayes; Karen S McCoy; Shahid I Sheikh
Journal: Am J Respir Crit Care Med Date: 2014-09-01 Impact factor: 21.405

2. Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy.

Authors: Andrea Kelly; Diva D De Leon; Saba Sheikh; Devaney Camburn; Christina Kubrak; Amy J Peleckis; Darko Stefanovski; Denis Hadjiliadis; Michael R Rickels; Ronald C Rubenstein
Journal: Am J Respir Crit Care Med Date: 2019-02-01 Impact factor: 21.405

3. Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis.

Authors: M Couce; T D O'Brien; A Moran; P C Roche; P C Butler
Journal: J Clin Endocrinol Metab Date: 1996-03 Impact factor: 5.958

4. Ivacaftor for the p.Ser549Arg (S549R) gating mutation - The Israeli experience.

Authors: Adi Dagan; Malena Cohen-Cymberknoh; Michal Shteinberg; Hagit Levine; Daphna Vilozni; Yael Bezalel; Bat-El Bar Aluma; Ifat Sarouk; Moshe Ashkenazi; Moran Lavie; Reuven Tsabari; Hannah Blau; Eitan Kerem; Lea Bentur; Ori Efrati; Galit Livnat
Journal: Respir Med Date: 2017-09-01 Impact factor: 3.415

5. Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure.

Authors: Rebecca L Hull; Ronald L Gibson; Sharon McNamara; Gail H Deutsch; Corinne L Fligner; Charles W Frevert; Bonnie W Ramsey; Srinath Sanda
Journal: Diabetes Care Date: 2018-02-01 Impact factor: 19.112

6. Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study.

Authors: Melena D Bellin; Theresa Laguna; Janice Leschyshyn; Warren Regelmann; Jordan Dunitz; JoAnne Billings; Antoinette Moran
Journal: Pediatr Diabetes Date: 2013-03-13 Impact factor: 4.866

7. Effect of Lumacaftor/Ivacaftor on glucose metabolism and insulin secretion in Phe508del homozygous cystic fibrosis patients.

Authors: Jan C Thomassen; Matthias I Mueller; Miguel A Alejandre Alcazar; Ernst Rietschel; Silke van Koningsbruggen-Rietschel
Journal: J Cyst Fibros Date: 2017-12-15 Impact factor: 5.482

8. CFTR Influences Beta Cell Function and Insulin Secretion Through Non-Cell Autonomous Exocrine-Derived Factors.

Authors: Xingshen Sun; Yaling Yi; Weiliang Xie; Bo Liang; Michael C Winter; Nan He; Xiaoming Liu; Meihui Luo; Yu Yang; Katie Larson Ode; Aliye Uc; Andrew W Norris; John F Engelhardt
Journal: Endocrinology Date: 2017-10-01 Impact factor: 4.736

9. CFTR potentiator therapy ameliorates impaired insulin secretion in CF patients with a gating mutation.

Authors: Reuven Tsabari; Hila Iron Elyashar; Malena Cohen Cymberknowh; Oded Breuer; Shoshana Armoni; Galit Livnat; Eitan Kerem; David Haim Zangen
Journal: J Cyst Fibros Date: 2015-11-04 Impact factor: 5.482

10. Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes.

Authors: Marika Bogdani; Scott M Blackman; Cecilia Ridaura; Jean-Pierre Bellocq; Alvin C Powers; Lydia Aguilar-Bryan
Journal: Sci Rep Date: 2017-12-08 Impact factor: 4.379

6 in total

Review 1. Update in Cystic Fibrosis 2018.

Authors: Bonnie W Ramsey; Gregory P Downey; Christopher H Goss
Journal: Am J Respir Crit Care Med Date: 2019-05-15 Impact factor: 21.405